<DOC>
	<DOCNO>NCT01924117</DOCNO>
	<brief_summary>Objective : Determine genotype risk factor associate human papilloma virus infection Mexican woman . Methods : It cross-sectional study woman attend Materno-Perinatal Hospital `` Mónica Pretelini '' Medical Research Center ( CICMED ) , ask complete risk factor questionnaire submit colposcopy identify SIL . Cervical swab sample obtain perform linear array HPV genotyping test ( Roche® , Mannheim , Germany ) .</brief_summary>
	<brief_title>Genotypification Predisposing Factors Human Papilloma Virus Infection</brief_title>
	<detailed_description>Principles : The aim study determine HPV genotypes squamous intraepithelial lesion ( SIL ) population sample State Mexico . Patients : The inclusion criterion woman submit colposcopy study Clinic 221 Mexican Social Security Institute ( IMSS ) , Maternal-Perinatal Hospital `` Monica Pretelini '' ( HMPMP ) , State Mexico Health Institute ( ISEM ) Medical Research Center ( CICMED ) , Autonomous University State México ( UAEMex ) . Women previous conization consider study whose clinical follow lose exclude . Sociodemographic factor : Patients give questionnaire measure follow potential risk factor : age , area residence , education level , sexual partner , participation anal sex , age first intercourse , smoking , use hormonal contraception , use condom , number pregnancy vaginal delivery . Cervical sample : Samples collect cervical scraping preserve ThinPrep® PreservCyt® Solution ( HologicTM Marlborough , Massachusetts , USA ) . HPV genotyping : DNA extraction cervical swab sample perform use Amplicor kit ( Roche® , Mannheim , Germany ) , isolate simultaneously β-globin gene along HPV . HPV positive specimen subsequently genotyped use Linear Array HPV Genotyping assay ( Roche® , Mannheim , Germany ) . This test qualitative vitro test detection HPV utilizing amplification target DNA Polymerase Chain Reaction ( PCR ) nucleic acid hybridization able detect 37 anogenital HPV DNA genotype ( 6 , 11 , 16 , 18 , 26 , 31 , 33 , 35 , 39 , 40 , 42 , 45 , 51 , 52 , 53 , 54 , 55 , 56 , 58 , 59 , 61 , 62 , 64 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 ( MM9 ) , 81 , 82 ( MM4 ) , 83 ( MM7 ) , 84 ( MM8 ) , IS39 CP6108 ) . This technique detect multiple HPV genotype sample . Ethical concern : We follow Declaration Helsinki patient ask sign write informed consent . This study accept Research Ethical Committee CICMED . Statistical analysis : First , descriptive analyzes perform , secondly , Odds Ratios ( OR ) associate 95 % confidence interval ( 95 % CI ) calculate well Chi-square test conditional regression model SIL use Statistical Package Social Sciences ( SPSS ) 17.0 software . Difference consider significant p ≤ 0.05 .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>Sexually active woman 18 40 year age come consult dysplasia clinic . Who pregnant Who receive pharmacological treatment antibiotic / antiinflammatory drug least one month study . Who agree participate study sign informed consent letter . Acceptance fill questionnaire relevant data relate HPV risk infection Inadequate sample Questionnaires incomplete data Women decide leave study</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>cervical intraepithelial neoplasia , HPV , Cancer</keyword>
</DOC>